These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8559496)

  • 21. [The effect of increasing ventral movement on the small solutes transport during peritoneal dialysis].
    Liu FY; Duan SB; Peng YM
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):347-50. PubMed ID: 12205997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between protein loss and dialysis duration results of PET and KT/Vurea in CAPD patients].
    Zhu JL; Duan SB; Liu FY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):233-4. PubMed ID: 12536691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting low values of serum albumin in CAPD patients.
    Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
    Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfer of autologous haemoglobin from the peritoneal cavity during peritoneal dialysis.
    Brouard R; Tozer TN; Baumelou A; Gambertoglio JG
    Nephrol Dial Transplant; 1992; 7(1):57-62. PubMed ID: 1316582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on kinetics of albumin in uraemic patients on chronic haemodialysis: evidence of interstitial albumin wash-down.
    Hildebrandt P; Jensen HA; Henriksen JH
    Clin Physiol; 1983 Apr; 3(2):153-62. PubMed ID: 6682736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal kinetics of different drugs.
    Keller E
    Clin Nephrol; 1988; 30 Suppl 1():S24-8. PubMed ID: 3180530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lyphatic absorption in CAPD patients with loss of ultrafiltration capacity.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Blood Purif; 1995; 13(6):327-39. PubMed ID: 8821197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial albumin mass and transcapillary extravasation rate of albumin in DMBA-induced rat mammary tumours.
    Reed RK; Wiig H
    Scand J Clin Lab Invest; 1983 Oct; 43(6):503-12. PubMed ID: 6419345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is high peritoneal transport rate an independent risk factor for CAPD mortality?
    Cueto-Manzano AM; Correa-Rotter R
    Kidney Int; 2000 Jan; 57(1):314-20. PubMed ID: 10620214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis.
    Lipkin GW; Forbes MA; Cooper EH; Turney JH
    Nephrol Dial Transplant; 1993; 8(4):357-60. PubMed ID: 8390012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluid transport in peritoneal dialysis.
    Lindholm B; Werynski A; Bergström J
    Int J Artif Organs; 1990 Jun; 13(6):352-8. PubMed ID: 2379969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan and its metabolites in patients on continuous ambulatory peritoneal dialysis and following renal transplantation.
    Qureshi AR; Lindholm B; Garcia E; Groth CG; Bergström J
    Nephrol Dial Transplant; 1994; 9(7):791-6. PubMed ID: 7526276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of tracer albumin from peritoneal cavity to plasma at low intraperitoneal volumes and hydrostatic pressures.
    Zhu Q; Carlsson O; Rippe B
    Perit Dial Int; 1998; 18(5):497-504. PubMed ID: 9848628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Krediet RT; Zuyderhoudt FM; Boeschoten EW; Arisz L
    Eur J Clin Invest; 1987 Feb; 17(1):43-52. PubMed ID: 3106050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes.
    Kagan A; Bar-Khayim Y
    Nephron; 1995; 71(3):314-20. PubMed ID: 8569981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis.
    Bazzato G; Fracasso A; Gambaro G; Baggio B
    Lancet; 1995 Sep; 346(8977):740-1. PubMed ID: 7658876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.